Aptamer Group is pleased to announce availability of Optimers[TM] as the new standard for their custom development services. Aptamer Group is dedicated to continually improve its service offerings to identify the best reagent(s) from within their vast aptamer libraries in the shortest time possible.As part of this process improvement they have recently validated their proprietary automated Minimal Aptamer Fragment Identification (MAFI) for the development of kinetically optimised aptamers in the same delivery time as their previous approach.
These improved aptamers will be differentiated from the standard library aptamers as Optimers[TM]. Kinetically optimised aptamers can have multiple advantages, when compared to their precursor aptamer sequences, making it an essential step in the development of the highest quality reagents against cellular, protein or small molecular targets.